Hyperion Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $226K | Buy |
+4,372
| New | +$226K | 0.14% | 67 |
|
|
2024
Q2 | – | Sell |
-4,368
| Closed | -$237K | – | 72 |
|
|
2024
Q1 | $237K | Sell |
4,368
-124
| -3% | -$6.73K | 0.17% | 57 |
|
|
2023
Q4 | $231K | Sell |
4,492
-3,964
| -47% | -$203K | 0.18% | 57 |
|
|
2023
Q3 | $491K | Sell |
8,456
-39
| -0.5% | -$2.26K | 0.42% | 31 |
|
|
2023
Q2 | $543K | Buy |
8,495
+33
| +0.4% | +$2.11K | 0.46% | 27 |
|
|
2023
Q1 | $587K | Buy |
8,462
+27
| +0.3% | +$1.87K | 0.53% | 24 |
|
|
2022
Q4 | $607K | Buy |
+8,435
| New | +$607K | 0.58% | 21 |
|